Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02670044
Title A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients Aged >/= 60 Years With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: senior
Covered Countries USA | ITA | FRA | CAN

Facility Status City State Zip Country Details
USC Norris Cancer Center Los Angeles California 90033 United States Details
UC Davis; Comprehensive Cancer Center Sacramento California 95817 United States Details
Univ of Calif, San Francisco San Francisco California 94143 United States Details
University of Colorado Aurora Colorado 80045-2517 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Weill Cornell Medical College New York New York 10065 United States Details
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Alberta Hospital Edmonton Alberta T6G 1Z1 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G 1Z5 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Hopital Avicenne, Paris Bobigny 93009 France Details
Institut Paoli Calmettes Marseille 13009 France Details
CHU de Bordeaux Pessac 33600 France Details
University of Bologna Bologna Emilia-Romagna 40126 Italy Details
Presidio san salvatore muraglia Pesaro Emilia-Romagna 61122 Italy Details
Universita di Roma Roma Emilia-Romagna 100 Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field